Crossmark

Hip resurfacing and posterior approach total hip arthroplasty have equivalent blood loss when tranexamic acid is used: a propensity score matched cohort analysis

Crossref DOI link: https://doi.org/10.1007/s00402-021-04272-6

Published Online: 2022-01-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Hanreich, Carola

Su, Edwin

Cororaton, Agnes

Lyman, Stephen

Jungwirth-Weinberger, Anna

Boettner, Friedrich https://orcid.org/0000-0002-7906-9486
License Information

Text and Data Mining valid from 2022-01-10

Version of Record valid from 2022-01-10
More Information

Article History

Received: 30 July 2021

Accepted: 19 November 2021

First Online: 10 January 2022

Declarations

:

: FB is consultant for Smith & Nephew, OrthoDevelopment, DePuy and Medtronic and receives Royalties from Smith & Nephew and OrthoDevelopment. ES receives royalties from Kyocera corporation, OrthAlign, United Orthopedic Corporation and is a paid consultant for Smith&Nephew, United Orthopedic Corporation and OrthAlign. SL is a paid consultant for CellSource (Tokyo, Japan) and Corin, Inc. (UK). None of the COIs are related to this research project. Remaining authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest or non-financial interest in the subject matter or materials discussed in this manuscript.

: The study was approved by the local Institutional Review Board of the senior author’s institution.

: Due to the retrospective design of the study it was not necessary to obtain informed consent.

Document is current

Any future updates will be listed below